Definitive Healthcare has acquired Monocl, a provider of medical and scientific expert data and insights. No financial terms were disclosed. Definitive Healthcare is backed by by 22C Capital, Advent International and Spectrum Equity.
FRAMINGHAM, MA – October 29, 2020 – Definitive Healthcare, the leading provider of data, intelligence, and analytics on the healthcare market, today announced its acquisition of Monocl, the pre-eminent subscription-based provider of medical and scientific expert data and insights. With this acquisition, Definitive Healthcare broadens its support of customers within its fast-growing life sciences segment with essential data assets and analytics designed to propel the work of Medical Affairs departments.
“The acquisition of Monocl brings together two powerful intelligence platforms to provide best-in-class data, analytics and insight that will help biotech and pharmaceutical companies accelerate clinical research and commercialization of new drugs and therapies,” said Jason Krantz, founder and CEO of Definitive Healthcare. “Monocl shares the Definitive philosophy of providing the highest quality data through an online interface that gives clients the ability to access and analyze real-time information and intelligence.”
Monocl delivers deep professional profiles on millions of experts worldwide to help companies identify and engage industry experts with the greatest knowledge, influence, and relevancy within the disease categories their drugs and therapies address. Traditionally, this data has been time-consuming to identify, inefficient, and incomplete, but the Monocl platform has transformed the whole expert identification and engagement by providing users with real-time access and searching for experts globally.
“Monocl further fortifies our team with experienced industry veterans and with a strong life sciences and healthcare network,” Krantz added. “Our combined offering will expand the value of the Definitive solution set by enabling our clients to research and engage prominent experts to advance drug and therapy research and go-to-market strategies.”
Through deep expert profiles and high data quality, targeted searching, and powerful filtering, the Monocl platform delivers algorithmically ranked experts of unmatched relevance to the user. Pharmaceutical professionals have the flexibility to identify and prioritize key influencers to support their specific objectives, evaluate spheres of influence, and share deep insights digital workspaces for multi-team collaboration.
“Monocl has always been laser focused on delivering critical expert insights through software to provide our clients with a unique competitive and collaborative edge,” said Bjorn Carlsson, CEO and co-founder of Monocl. “We are thrilled to unite the power of our groundbreaking expert platform with Definitive’s comprehensive and complementary healthcare provider platform and medical claims analytics. This is truly an example of the whole being much greater than the sum of its parts.”
With this acquisition, Definitive Healthcare fortifies its product offerings for life sciences companies by delivering relevant data sets and analytics to both commercial teams Medical Affairs departments. In addition, Definitive expands its international presence from North America to Europe and Asia.
In 2020, Definitive Healthcare was, again, named to the Inc. 5000 Fastest-Growing Private Companies, Deloitte’s Technology Fast 500, and to the Boston Business Journal’s Fast 50. The Company was also recognized with the 2020 CODiE product award for Best Big Data Reporting and Analytics Solution and with the 2020 MedTech Breakthrough award for Best Healthcare Data Platform. For the second consecutive year, Definitive Healthcare was awarded a Silver Stevie Award for industry-leading Customer Service and Satisfaction. Definitive was also named Massachusetts’ #1 Best Large Company to Work for in 2019 by the Boston Business Journal.
“It was really important for us to join forces with a partner that shares our commitment to customers and to providing products enabling the best insights possible. We could not have found a better match, and our entire team is thrilled to be joining the Definitive family,” said Carlsson.
Monocl will continue to serve its worldwide customer base under its current brand, as a Definitive Healthcare Company, and will maintain its existing operations in the US and Sweden. Bjorn Carlsson will be a member of Definitive Healthcare’s executive leadership team.
About Definitive Healthcare
Definitive Healthcare is the most comprehensive and accurate source for data insights and analytics on the healthcare provider and influencer market. Its product suite provides the most comprehensive and highest quality data available anywhere on 8,800 hospitals and IDNs; 135,000 physician groups; 1.7 million physicians, nurses, and allied health professionals; 11,000 ambulatory surgery centers; 15,800 imaging centers; 85,500 long-term care facilities; 40,000 clinics; 1,800 ACOs and HIEs; 5.7 billion medical commercial claims covering 315 million patient lives, and insights on millions of Key Opinion Leaders in life sciences and healthcare. The company’s data provides its 2,500 clients with the analytics and insight needed to effectively segment and research the healthcare provider market. Definitive Healthcare is backed by 22C Capital, Advent International, and Spectrum Equity. For more information, or to trial the service, visit https://www.definitivehc.com/.
Monocl empowers life science professionals with the complete global expert solution designed to drive impactful outreach and strategic engagement. Our cloud-based expert platform – powered by machine learning – continuously analyzes an unrivaled amount of data across all therapeutic areas and regions, providing invaluable context and actionable insights. For more information, including details on how to get product access, visit https://www.monocl.com/.